Alere/HIP team up on remote CHF (congestive heart failure) monitoring:
This article was originally published in Clinica
Executive Summary
New York health plan HIP has become the first in the eastern US to introduce a remote monitoring system for congestive heart failure (CHF) patients. The system uses Alere Medical technology in a programme that enables doctors to intervene at critical stages by viewing real time information on patient symptoms. CHF affects some 5m people in the US, with new cases being diagnosed at the rate of 400,000 per year. Hospitalisation costs exceed $6bn. A quarter of a million patients die from the condition annually. HIP serves some 800,000 members.